RAPT Therapeutics, Inc. (NASDAQ:RAPT) Receives $5.29 Average Target Price from Analysts
Shares of RAPT Therapeutics, Inc. (NASDAQ:RAPT – Get Free Report) have been assigned an average recommendation of “Hold” from the nine ratings firms that are currently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and two have issued a […]
Shares of RAPT Therapeutics, Inc. (NASDAQ:RAPT – Get Free Report) have been assigned an average recommendation of “Hold” from the nine ratings firms that are currently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and two have issued a […]
